Quality of life in kidney recipients: Comparison of tacrolimus and cyclosporine-microemulsion

Clinical Transplantation

Volumn 16, Issue 1, 2002, Pages 48-54

  Reimer, Jens ^a   Franke, Gabriele H ^a   Philipp, Thomas ^a   Heemann, Uwe ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cyclosporine; Immunosuppressive agents; Kidney transplantation; Quality of life; Tacrolimus

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; GINGIVA HYPERPLASIA; GINGIVITIS; HEALTH SURVEY; HIRSUTISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RECIPIENT; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SURVIVAL; WINTER;

ADULT; ANALYSIS OF VARIANCE; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TACROLIMUS;

EID: 0036109778     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2002.00071.x     Document Type: Article

References (36)

1. Annual Report of the German Renal Registry 1998
2. Determining the quality of life in the renal replacement therapies
3. Renal transplantation - Improving the quality of life
4. Factors determining the rate of referral, transplantation, and survival on dialysis in women with ESRD
5. Selection-adjusted comparison of life-expectancy of patients on continous ambulatory peritoneal dialysis, hemodialysis, and renal transplantation
6. Prognostically controlled comparison of dialysis and renal transplantation
7. Survival with dialysis and transplantation in patients with end-stage renal disease
8. Results of treatment in patients with end-stage renal disease: A multivariate analysis of risk factors and survival in 341 successive patients
9. Survival of patients who have been on a waiting list for transplantation
10. Comparison of survival probabilities for dialysis patients versus cadaveric renal transplant recipients
11. A study of the quality of life and cost utility of renal transplantation
12. Cost-effectiveness studies of renal transplantation
13. Economic evaluation of end stage renal disease treatment
14. Does transplantation produce quality of life benefits?
15. Quality of life in patients before and after kidney transplantation
16. Health-related quality of life in endstage renal failure
17. Survival trends in long-term first cadaverdonor kidney transplants
18. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival
19. Liver transplantation in the ciclosporin era
20. Mode of action of tacolimus (FK506): Molecular and cellular mechanisms
21. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation
22. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group
23. Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection
24. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation
25. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
26. Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine -based immunosuppression
27. Cyclosporine microemulsion (Neoral): A pharmocoeconomic review of its use compared with standard cyclosporine in renal and hepatic transplantation
28. Factors affecting compliance with cyclosporine in adult renal transplant patients
29. Compliance and noncompliance in patients with a functioning renal transplant: A multicenter study
30. Quality of life advantages of FK506 vs conventional immunosuppressive drug therapy in cardiac transplantation
31. Comparison of cyclosporine A and FK 506 with regard to complaints and psychosocial characteristics before and after liver transplantation
32. Changes in quality of life following conversion from CyA to FK 506 in orthoptopic liver transplant patients
33. The MOS 36-item short form health survey (SF-36)
34. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation
35. Quality of life in end-stage renal disease patients after successful kidney transplantation: Development of the ESRD Symptom Checklist - Transplantation Module